Home / Health / Low-Risk Patients Can Ditch Beta-Blockers After Heart Attack
Low-Risk Patients Can Ditch Beta-Blockers After Heart Attack
5 Apr
Summary
- Low-risk heart attack survivors may stop beta-blockers after one year.
- Study found similar outcomes for stopping vs. continuing beta-blockers.
- Discontinuation can improve quality of life by reducing side effects.
A new study presented at the American College of Cardiology's Annual Scientific Session indicates that some heart attack survivors might no longer need to take beta-blockers indefinitely. Researchers in South Korea analyzed data from over 2,500 participants, finding that low-risk patients who discontinued beta-blockers after at least one year experienced similar outcomes to those who continued the medication.
The study, published in The New England Journal of Medicine, revealed that over a median follow-up of 3.1 years, the primary endpoint of death, recurrent heart attack, or heart failure hospitalization occurred in 7.2% of those who stopped beta-blockers compared to 9% in the group that continued them.
Cardiologists suggest this research challenges a long-standing treatment protocol. For carefully selected patients without heart failure or significant systolic dysfunction, routine indefinite use of beta-blockers may not be required. This shift could improve patients' quality of life by reducing potential side effects like fatigue and dizziness.
Experts emphasize that this is not a universal green light to stop medication but rather an invitation for shared decision-making between doctors and stable, low-risk patients. Further research is needed to confirm these findings in more diverse populations.
